NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis

PHASE4CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Ankylosing Spondylitis
Interventions
BIOLOGICAL

Golimumab

DRUG

Celecoxib

Trial Locations (19)

10117

Charite Universitaetsmedizin - Dpt. Rheumatology at Campus Charite Mitte, Berlin

12161

Rheumatologische Schwerpunktpraxis, Berlin

12163

Rheumatologische Praxis Dr. Karberg/Brandt, Berlin

12200

Charite Universitaetsmedizin, Dpt. of Rheumatology at Campus Benjamin Franklin, Berlin

12627

MVZ Drs. Mielke, Berlin

13055

Rheumapraxis Dr. Zinke, Berlin

14059

Schlossparkklinik, Dpt. of Rheumatologie, Berlin

30625

Medizinische Hochschule, Rheumatologie, Hanover

39104

Rheumapraxis Magdeburg, Magdeburg

39340

Praxis Dr Kühne, Haldensleben I

44649

Rheumazentrum Ruhrgebiet, Herne

50937

Universitätsklinikum Köln, Rheumatologie, Cologne

60528

Centrum für innovative Diagnostik und Therapie Rheumatologie/Immunologie (CIRI), Frankfurt am Main

72072

Rheumapraxis Dr. Jacki, Tübingen

72076

University of Tuebingen, Dpt. Rheumatology, Tübingen

81675

Klinikum Rechts der ISAR (TU München), München

84489

Rheumatologische Schwerpunktpraxis an den Kreiskliniken, Burghausen

95444

Rheumapraxis Bayreuth Dr. Ochs, Bayreuth

04600

Rheumapraxis Kupka, Altenburg

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT02758782 - NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter